Cargando…
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype accounting for approximately 10–20% of all cases. Due to a lack of actionable targets, chemotherapy has been for many decades the preferred, and often the only, available treatment option for this disea...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252021/ https://www.ncbi.nlm.nih.gov/pubmed/37296893 http://dx.doi.org/10.3390/cancers15112933 |